Takeda’s oral TYK2 inhibitor showed rapid skin clearance in phase 3 psoriasis trials as FDA fast-tracks review; decision expected early 2027.
News|Articles|September 14, 2005
Tinea Cruris
Author(s)Robert P. Blereau, MD
A 56-year-old man had an asymmetric, maculopapular, sharply demarcated, pruritic, excoriated dermatitis on his upper thighs. The eruption had been present for 2 to 3 weeks.
Advertisement
A 56-year-old man had an asymmetric, maculopapular, sharply demarcated, pruritic, excoriated dermatitis on his upper thighs. The eruption had been present for 2 to 3 weeks.
A potassium hydroxide preparation revealed fungal elements. Unlike a Candida infection of the groin, tinea cruris usually is more confined and spares the scrotum. Oral and topical ketoconazole were given; the dermatophytosis completely resolved in 3 weeks.
Advertisement
Related to this article
FDA approved Pfizer-BioNTech’s XFG-adapted COMIRNATY formula for adults 65 and older and high-risk people aged 5 to 64 years.
A Vaccine Integrity Project review found influenza, COVID-19, and RSV immunizations continue to protect against severe illness, hospitalization, and death.
FDA approved bictegravir/lenacapavir for adults with suppressed HIV-1 and no known or suspected component resistance.
FDA expands dolutegravir dispersible tablets to children with HIV-1 weighing at least 2 kg, including eligible term newborns.
Pre-existing antibodies to common microbes predicted COVID-19 vaccine response strength in healthy and immunosuppressed adults.
The organizations challenge a presidential executive order narrowing routine childhood vaccine recommendations and urging vaccines to be given separately.
FDA acceptance starts review of clesrovimab for second-season RSV prevention in high-risk children younger than 2 years.
Advertisement
Advertisement
Trending on Patient Care Online
1
ASH Raises Ferritin Thresholds for Diagnosing Iron Deficiency
2
Combating Prostate Cancer Misconceptions in Primary Care: An Expert Discussion
3
Endocrine Society Obesity Statement Calls for Goals Beyond Weight Loss
4
FDA Approves Finerenone for CKD Associated With Type 1 Diabetes
5